semaglutide being taken off the market Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s Semaglutide shortage ends as FDA

Further validation of these findings in larger external cohorts would be useful

It helps them internalize that obesity is about biology, not just choices

But compounding is also allowed when drugs are facing shortageslike the highly popular Wegovy and Ozempic were

100-unit syringe: Necessary for larger doses or lower concentrations that require higher volumes

GLP-1 medications mimic a hormone your body already produces GLP-1 which helps regulate appetite, blood sugar, gastric emptying, and the brain's reward response to food

Heterogeneity was 20.45% with no evidence of publication bias on visual inspection of funnel plot (Supplemental Fig